Substance
PANITUMUMAB
Global reference: every product and company linked to this substance.
- cas: 339177-26-3
- ncit: C1857
- rxnorm: 263034
- unii: 6A901E312A
ABENIX · ABX-EGF · E7.6.3 · panitumumab [INN] · PANITUMUMAB [JAN] · PANITUMUMAB [USAN] · Panitumumab [WHO-DD]
Revenue by product (1)
| Company | Product | Latest period | Revenue |
|---|---|---|---|
| AMGEN INC. COMMON STOCK | VECTIBIX | Q2 2026 | $338.0M |
A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.
Products containing this substance (1)
- VECTIBIX · AMGEN INC. COMMON STOCK